Athersys Inc (ATHX)

Check out top investors' recommendation for ATHX
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
9.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company’s lead platform product, MultiStem, an allogeneic stem cell product, which was evaluated in two completed Phase I clinical trials and is under two ongoing Phase II clinical trials for treating a range of diseases and various application in the field of clinical regenerative medicine. Its clinical development programs are focused on treating inflammatory and immune disorders, neurological conditions, cardiovascular disease, and other conditions. The company is also involved in identifying and developing novel pharmaceuticals to treat obesity; related metabolic conditions, such as diabetes; and neurological indications, including schizophrenia. It has collaboration agreement with Pfizer Inc. to develop and commercialize MultiStem to treat inflammatory bowel disease; and RTI Biologics, Inc. to develop and commercialize biologic implants for orthopedic applications in the bone graft substitutes market. The company was founded in 1995 and is based in Cleveland, Ohio.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Stephen Brozak WBB Securities, LLC Buy   Oct 04, '18     9.00  Oct 04, '19  N/A 
Jason Kolbert Maxim Group Buy   Feb 13, '18     6.00  Feb 13, '19  N/A 
Jason Kolbert Maxim Group Buy   Nov 09, '17     12.00  Nov 09, '18  N/A 
Jason Kolbert Maxim Group Buy   Oct 05, '17     12.00  Oct 05, '18  N/A 
Jason Kolbert Maxim Group Buy   Aug 07, '17     9.00  Aug 07, '18  N/A 
Jason Kolbert Maxim Group Buy   May 10, '17       May 10, '18  N/A 
Jason Kolbert Maxim Group Buy   Sep 12, '16       Sep 12, '17  N/A 
Jason Kolbert Maxim Group Buy   Feb 17, '16   1.45  5.00  Feb 17, '17  -18.62% 
Stephen Brozak WBB Securities, LLC Buy   Jan 08, '16   1.25  9.00  Jan 08, '17  21.60% 
Jason Kolbert Maxim Group Buy   Dec 22, '15   1.08  5.00  Dec 22, '16  42.59% 
Greg Chodaczek First Analysis Corp. Buy   Apr 29, '14   1.43    Apr 29, '15  -9.79% 
Jason Kolbert Maxim Group Buy   Oct 04, '12   1.31  6.00  Oct 04, '13  22.90% 
Jason Kolbert Maxim Group Buy   May 30, '12   1.42  3.00  May 30, '13  25.35% 
Edward Tenthoff Piper Jaffray Buy   Mar 19, '12   1.67  4.00  Mar 19, '13  -7.78%